Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024)

Arcus Biosciences has reported Other Operating Expenses over the past 2 years, most recently at $20.0 million for Q1 2024.

  • Quarterly results put Other Operating Expenses at $20.0 million for Q1 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $20.0 million (changed N/A YoY), and the annual figure for FY2024 was $20.0 million, changed.
  • Other Operating Expenses for Q1 2024 was $20.0 million at Arcus Biosciences, up from -$248000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for RCUS hit a ceiling of $20.0 million in Q1 2024 and a floor of -$248000.0 in Q4 2020.